Akèy › Timò Nèwo-endokrin › Kalifòni
Etid klinik pou Timò Nèwo-endokrin nan Kalifòni
13 etid pou Timò Nèwo-endokrin ap chèche patisipan nan sit nan Kalifòni.
Vil nan Kalifòni
- Los Angeles5 etid
- Mountain View5 etid
- San Francisco5 etid
- Baldwin Park4 etid
- San Diego3 etid
- Orange3 etid
Tèks ofisyèl etid la (Anglè)
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
- Cedars-Sinai Medical Center, Beverly Hills
- Norris Comprehensive Cancer Center, Los Angeles
- Stanford Cancer Center, Palo Alto
- ak 2 plis
Ap rekriteFaz 2/3
Laj 18 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT06943755Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors
- UCSF Benioff Children's Hospital, San Francisco
Ap rekriteFaz 1
24 Months – 18 Years · Tout sèks · Mizajou Sep 25, 2026 · NCT06441331Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen
- Hoag Memorial Hospital Presbyterian, Newport Beach
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 15, 2026 · NCT07087054Project: Every Child for Younger Patients With Cancer
- Kaiser Permanente Downey Medical Center, Downey
- City of Hope Comprehensive Cancer Center, Duarte
- Loma Linda University Medical Center, Loma Linda
- ak 15 plis
Ap rekriteEtid obsèvasyon
Jiska laj 25 · Tout sèks · Mizajou Aug 25, 2026 · NCT02402244A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid Tumors
- Crinetics Study Site, Duarte
- Crinetics Study Site, Newport Beach
- Crinetics Study Site, Orange
- ak 1 plis
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Jul 31, 2026 · NCT07129252CapTemY90 for Grade 2/3 NET Liver Metastases
- UC San Diego, La Jolla
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Jun 4, 2026 · NCT04339036A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
- St Joseph Heritage Healthcare, Santa Rosa
Ap rekriteFaz 1/2
Laj 12 ak plis · Tout sèks · Mizajou May 27, 2026 · NCT03093116Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
- Stanford University, Palo Alto
Ap rekriteFaz 1/2
Laj 20 a 99 · Tout sèks · Mizajou Apr 20, 2026 · NCT02174549Lenvatinib Plus Pembrolizumab in Well Differentiated G3 Neuroendocrine Tumors
- University of California, San Francisco, San Francisco
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Mar 17, 2026 · NCT05746208Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
- City of Hope, Duarte
- UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
- Stanford Cancer Institute, Stanford
Ap rekriteFaz 1
Laj 18 a 75 · Tout sèks · Mizajou Mar 17, 2026 · NCT04119024Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes
- Cedars-Sinai Medical Center, Los Angeles
Ap rekrite
Laj 18 a 99 · Tout sèks · Mizajou Feb 20, 2026 · NCT04907643A Study of MT-4561 in Patients With Various Advanced Solid Tumors
- University of Southern California, Los Angeles
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Dec 11, 2025 · NCT06943521SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Duarte
- Massive Bio SYNERGY-AI site, Irvine
- Massive Bio SYNERGY-AI site, La Jolla
- ak 3 plis
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Oct 28, 2025 · NCT03452774Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.